Match Document Document Title
6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use  
Disclosed are hxuB and hxuC genes and DNA segments from H. influenzae such as H. influenzae type b (Hib) and nontypeable H. influenzae (NTHI). The HxuB and HxuC proteins, being surface expressed,...
6017542 Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor  
Disclosed and claimed are nucleotides for genes encoding the canine herpesvirus (CHV) gB, gC and gD homologues. These genes encode polypeptides of 879, 459 and 345 amino acids, respectively, which...
6017535 cDNA sequence of Dengue virus serotype 1 (Singapore strain)  
DENI-S275/90 (ECACC V92042111) is a new strain of Dengue virus serotype 1. The complete cDNA sequence of this virus has been cloned and protein-coding fragments thereof have been used in the...
6017730 Method of limiting the survival of genetically engineered microorganisms in their environment  
The survival of cells is limited by introducing into the cells a regulatably expressible gene whose expression results in the formation of a cytoplasmatically active hydrolytic enzyme. Populations...
6015694 Method for stimulating an immune response utilizing recombinant alphavirus particles  
The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector...
6015696 Mycobacterial secretory expression vectors and transformants  
A secretory vector expressed in mycobacteria comprising a promoter, a signal sequence having ligated therewith a DNA nucleotide sequence encoding heterologous polypeptide and replicator region...
6013481 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof  
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as GAGE tumor...
6013432 Immunoassay of HIV antibodies using recombinant or synthetic selected pol sequence  
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome,...
6013262 Recombinant papilloma virus L1  
This invention relates to a recombinant papilloma virus L1 protein which can elicit an immune response which recognises papilloma virus VLP including L1 protein and can form extracellularly a...
6013261 Recombinant Marek's disease virus (MDV) and vaccine  
A recombinant herpes virus is provided which efficiently expresses an exogenous protein of interest in an inoculated animal host to thereby endow the host with excellent immunization. A recombinant...
6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them  
The present invention provides papillomavirus DNA, and more particularly DNA probes derived from papillomavirus. The present invention also provides procedures for the use of DNA derived from...
6008021 DNA encoding serS polypeptides  
The invention provides serS polypeptides and DNA (NA) encoding serS polypeptide and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing serS...
6008342 DNA encoding eimeria antigen  
The invention provides an immunogenic polypeptide having the amino acid sequence TBL M A K S M L S G I V F A G L V A A A A A - S S A N S A A N V S V L E S G P A V Q E - V P A R T V T A R L A K P L...
6001599 DNAs encoding mammalian ZPBs  
A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active...
6001600 DNA encoding tests polypeptides  
Novel response regulator polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for...
6001603 Phosphoribosyl transferase  
The invention provides phosphoribosyl transferase polypeptides and DNA (RNA) encoding phosphoribosyl transferase polypeptides and methods for producing such polypeptides by recombinant techniques....
6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor  
EBI 3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing EBI 3 polypeptides and...
6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides  
The invention provides ileS polypeptides and DNA (RNA) encoding ileS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing ileS...
6001360 Method and compositions for early detection and treatment of insulin dependent diabetes mellitus  
Compositions and methods for the treatment or prevention of insulin dependent diabetes (IDD) are provided. Specifically, glutamic acid decarboxylase (GAD) proteins, and fragments. thereof, can be...
5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome  
The invention provides fragments of GAD 65 that are specifically reactive with at least one class of GAD 65 autoantibody. Most fragments are substantially free of N-terminal amino acids that...
5993821 Modified papilloma virus L2 protein and VLPs formed therefrom  
The invention, in one aspect, is directed to a modified papilloma virus L2 protein which does not bind DNA or which has a substantially impaired ability to bind DNA compared to wild-type papilloma...
5994525 Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins  
The invention provides a vaccine for the prevention and/or the treatment of infection by Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, which vaccine contains at...
5993826 Methods and compositions relating to useful antigens of moraxella catarrhalis  
The present disclosure relates to Moraxella catarrhalis outer membrane vesicle (OMV) compositions, to selected antigenic proteins from the outer membranes of M. catarrhalis which have a variety of...
5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences  
Attenuated respiratory syncytial virus (RSV) and vaccine compositions thereof are produced by introducing specific mutations associated with attenuating phenotypes into wild-type or RSV which is...
5994101 DNA encoding gidA1 polypeptides  
The invention provides gidA1 polypeptides and DNA (RNA) encoding gidA1 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing...
5989864 DNA encoding spo-rel polypeptides  
Spo-rel polypeptides and DNA (RNA) encoding such spo-rel and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such...
5985285 Vaccines for plague  
A method of protecting a human or animal body from the effects of infection with Y. pestis is provided comprising administering to the body a vaccine including Yersinia pestis V antigen and...
5985609 Process for preparing hepatitis C virus envelope glycoproteins  
The present invention relates to a novel process for preparing hepatitis C virus (HCV) envelope glycoproteins employing Chinese Hamster Ovary (CHO) cells transformed with recombinant expression...
5981224 Bovine heat shock promoter and uses thereof  
A novel expression system using the heat-inducible bovine hsp70A promoter and associated cis-acting elements is disclosed. The system provides for the continuous production of a highly pure,...
5981229 Bacterial exported proteins and acellular vaccines based thereon  
Provided herein are novel nucleic acids which encode exported proteins of Gram positive bacteria, and the proteins encoded by such nucleic acids. Also provided are methods of producing such...
5981228 Mammalian ZPAs  
A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active...
5976552 Virus vaccines  
Improved mammalian virus vaccines are combinations that contain an immunogenic amount of inactivated virus, such as influenza virus, Herpes varicella virus, measles virus, Epstein Barr virus,...
5977339 Methods and compositions for diagnosing lyme disease  
A chromosomal gene of Borrelia burgdorferi which encodes a conserved antigen of approximately 79 kD has been isolated and sequenced. The chromosomal gene, the gene product, and antibodies to the...
5976840 Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae  
The invention provides gluS polypeptides and DNA (RNA) encoding gluS polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing gluS...
5977306 Parasitic helminth P39 proteins, and uses thereof  
The present invention relates to parasitic helminth proteins of about 39 kD (i.e., P39 proteins); to parasitic helminth P39 nucleic acid molecules, including those that encode such proteins; and to...
5976839 Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules  
A class of carrier molecules which when covalently linked to an immunogen enhances the host's immune response to that immunogen, regardless of whether the complex of carrier and immunogen is...
5972659 Multispecific antigenic proteins  
A novel conjugated protein produced by recombinant DNA techniques comprises a low molecular weight carrier protein portion that is normally self-aggregating to an immunogenic higher molecular...
5972657 Gene encoding outer membrane protein B1 of moraxella catarrhalis  
Nucleotide sequences, derived from Moraxella catarrhalis, which encode one or more epitopes of outer membrane protein B1 are disclosed. Recombinant B1 protein or B1 peptides may be produce by...
5972656 Mercury binding polypeptides and nucleotides coding therefore  
Metal binding polypeptides which include an amino acid sequence coding for a variable region of a monoclonal antibody which immunoreacts with a mercury cation and nucleotides which include a...
5972597 Methods using modified vaccinia virus  
What are disclosed are methods for modifying the genome of vaccinia virus to produce vaccinia mutants, particularly by the introduction into the vaccinia genome of exogenous DNA; modified vaccinia...
5968522 Immunogenic compositions and antibodies directed against human papillomavirus type 49 (HPV 49), type 50 (HPV 50), type 54 (HPV 54), and type 55 (HPV 55).  
The invention relates to papillomavirus probes derived from new DNA-HPVs deposited with the CNCM on the May 6, 1988 under the following filing numbers: PGEM 4 HPV49: I-754 PSP 65 HPV50: I-755...
5968777 DNA encoding seryl t-RNA synthetase  
The invention provides serS polypeptides and DNA (RNA) encoding serS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing serS...
5968775 Hepatitis C virus infected cell systems  
The present invention is directed to extracorporeal cell systems infected with hepatitis C virus (HCV). The present invention also relates to products of such cell systems and their use as vaccines...
5965139 Chicken infectious anemia virus vaccine  
Novel sequences in the genome of a wild type isolate of chicken infectious anemia virus are described, The amino acid sequence of a polypeptide, VP1, encoded by a novel sequence is also disclosed....
5965401 Purified mammalian NK antigens and related reagents  
NK cell surface antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this antigen. Methods of using those reagents and...
5965400 DNA encoding a truncated pneumogoccal surface protein (PspA)  
A purified pneumococcal surface protein A (PspA) comprises a truncated form of the PspA protein which is immunoprotective and contains the protective epitopes of PspA. The PspA protein is soluble...
5965140 Hybrid particle immunogens  
Novel immunogenic compositions are provided involving viral particles composed at least in part of hybrid proteins of at least a portion of a particle forming protein and one or more polypeptides...
5965124 Replication-competent recombinant viral vaccines and method of producing same  
Replication-competent recombinant viruses, particularly replication-competent recombinant polioviruses, which include (1) exogenous nucleic acid sequences which encode an exogenous polypeptide and...
5965402 DNA encoding phoH polypeptides  
The invention provides phoH homolog polypeptides and DNA (RNA) encoding phoH homolog polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods...
5961983 Stable pura vectors and uses therefor  
This invention pertains to a complementation system for the selection and maintenance of expressed genes in bacterial hosts. The invention provides stable vectors which can be selected and...